Although IL-18 levels exhibited a decreasing trend without reaching statistical significance, the overall suppression of inflammasome components suggests that SIM interferes with both the priming and activation phases of NLRP3 signaling.
← all excerpts
Simvastatin Attenuates Doxorubicin-Induced Inflammation in Human Cardiomyocytes.
1
—
—